David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Netflix
NFLX
|
+$751M |
| 2 |
Advanced Micro Devices
AMD
|
+$751M |
| 3 |
Micron Technology
MU
|
+$426M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$363M |
| 5 |
ExxonMobil
XOM
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$546M |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$485M |
| 3 |
VMW
VMware, Inc
VMW
|
+$393M |
| 4 |
Microsoft
MSFT
|
+$336M |
| 5 |
UnitedHealth
UNH
|
+$303M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.03% |
| 2 | Consumer Discretionary | 9.51% |
| 3 | Healthcare | 5.77% |
| 4 | Financials | 5.47% |
| 5 | Communication Services | 4.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VTYX
2826
DELISTED
Ventyx Biosciences
VTYX
| $1.27M | ﹤0.01% |
+514,619
| New | +$4.89M |
|
2827
Marcus Corp
MCS
$930M
| $1.27M | ﹤0.01% |
87,151
-4,274
| -5% | -$64K |
|
2828
CALL
American Eagle Outfitters
AEO
$2.8B
| $1.27M | ﹤0.01% |
60,000
| – | – |
|
|
THR
2829
DELISTED
Thermon Group Holdings
THR
| $1.27M | ﹤0.01% |
38,974
-13,553
| -26% | -$404K |
|
2830
Marqeta
MQ
$1.7B
| $1.27M | ﹤0.01% |
45,430
-130,701
| -74% | -$3.13M |
|
|
DMC
2831
Del Monte Corp
DMC
$1.5B
| $1.27M | ﹤0.01% |
48,250
+26,837
| +125% | +$661K |
|
2832
NovaGold Resources
NG
$4.29B
| $1.27M | ﹤0.01% |
338,580
+156,354
| +86% | +$587K |
|
2833
CVRx
CVRX
$89.8M
| $1.27M | ﹤0.01% |
40,273
+20,842
| +107% | +$391K |
|
2834
CALL
Toll Brothers
TOL
$13.9B
| $1.26M | ﹤0.01% |
+12,300
| New | +$1.02M |
|
2835
Ethan Allen Interiors
ETD
$605M
| $1.26M | ﹤0.01% |
39,568
-28,250
| -42% | -$810K |
|
2836
Encompass Health
EHC
$11.9B
| $1.26M | ﹤0.01% |
+18,902
| New | +$1.22M |
|
2837
CorVel
CRVL
$3.54B
| $1.26M | ﹤0.01% |
15,291
| – | – |
|
2838
Cooper-Standard Automotive
CPS
$474M
| $1.26M | ﹤0.01% |
64,454
+47,336
| +277% | +$755K |
|
2839
Rogers Communications
RCI
$19.8B
| $1.25M | ﹤0.01% |
26,809
+19,609
| +272% | +$817K |
|
2840
Greif
GEF
$4.81B
| $1.25M | ﹤0.01% |
19,063
-46
| -0.2% | -$3.03K |
|
2841
CALL
Nu Holdings
NU
$73.1B
| $1.25M | ﹤0.01% |
150,000
+87,500
| +140% | +$707K |
|
2842
Ribbon Communications
RBBN
$368M
| $1.25M | ﹤0.01% |
430,612
-103,028
| -19% | -$232K |
|
2843
Franklin FTSE Japan ETF
FLJP
$4.09B
| $1.25M | ﹤0.01% |
+44,584
| New | +$1.19M |
|
|
TWO
2844
Two Harbors Investment
TWO
$1.28B
| $1.24M | ﹤0.01% |
89,228
+67,619
| +313% | +$874K |
|
2845
Constellium
CSTM
$3.67B
| $1.24M | ﹤0.01% |
62,015
-221,608
| -78% | -$3.88M |
|
|
BCOV
2846
DELISTED
Brightcove, Inc.
BCOV
| $1.24M | ﹤0.01% |
477,887
+91,773
| +24% | +$246K |
|
2847
PUT
Murphy Oil
MUR
$4.96B
| $1.24M | ﹤0.01% |
29,000
| – | – |
|
2848
Scotiabank
BNS
$113B
| $1.24M | ﹤0.01% |
25,400
-25,209
| -50% | -$1.11M |
|
2849
PUT
St. Joe Company
JOE
$3.96B
| $1.23M | ﹤0.01% |
+20,500
| New | +$1.08M |
|
2850
Innospec
IOSP
$2.32B
| $1.23M | ﹤0.01% |
10,008
-9,022
| -47% | -$960K |
|
Similar funds
David Shaw's Q4 2023 Portfolio in Review
As of Q4 2023, David Shaw held 4,806 positions worth $114B, up 19% from $95.8B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
David Shaw's Q4 2023 filing shows 575 new, 1,549 increased, 1,464 reduced and 527 closed positions. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $546M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- David Shaw's largest Q4 2023 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,424,593 shares worth $188M.
- David Shaw added most to Netflix in Q4 2023, an estimated $751M increase.
- David Shaw's biggest Q4 2023 reduction was Microsoft, cutting an estimated $336M.
- David Shaw fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $546M.
- David Shaw's ten largest holdings make up 12% of its $114B portfolio in Q4 2023.
- David Shaw opened 575 new positions and closed 527 in Q4 2023.
- David Shaw's portfolio value rose 19% quarter-over-quarter to $114B.
Based on D.E. Shaw & Co's 13F filing for Q4 2023, filed 14 Feb 2024.